Join the Fluzone group to help and get support from people like you.
Fluzone News (Page 2)
In Good News for U.S., Flu Vaccine Working Well in South America
MONDAY, Sept. 11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South A...
Recommendations Updated for Flu Vaccine in Children
TUESDAY, Aug. 29, 2023 – Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical...
Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
PARIS, Nov. 4, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for...
Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent
SWIFTWATER, Pa., Dec. 12, 2014 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...
New Fluzone Quadrivalent Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
• The first and only 4-strain influenza vaccine option for patients as young as six months of age, • Helps protect children and adults against additional influenza B strain, • Newes...
FDA Licenses Fluzone Intradermal - Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection
Swiftwater, Pa — May 10, 2011 /PRNewswire/ — Sanofi Pasteur, the vaccines division of Sanofi announced today the U.S. Food and Drug Administration (FDA) has approved the company's supplemental bio...
Ask a question
To post your own question to this support group, sign in or create an account.